Dihydroxypyrimidine-4-carboxamides as Novel Potent and Selective HIV Integrase Inhibitors
作者:Paola Pace、M. Emilia Di Francesco、Cristina Gardelli、Steven Harper、Ester Muraglia、Emanuela Nizi、Federica Orvieto、Alessia Petrocchi、Marco Poma、Michael Rowley、Rita Scarpelli、Ralph Laufer、Odalys Gonzalez Paz、Edith Monteagudo、Fabio Bonelli、Daria Hazuda、Kara A. Stillmock、Vincenzo Summa
DOI:10.1021/jm070027u
日期:2007.5.1
chemotherapeutic intervention in the treatment of AIDS that has also recently been confirmed in the clinical setting. We report here on the design and synthesis of N-benzyl-5,6-dihydroxypyrimidine-4-carboxamides as a class of agents which exhibits potent inhibition of the HIV-integrase-catalyzed strand transfer process. In the current study, structural modifications on these molecules were made in order
人类免疫缺陷病毒1型(HIV-1)整合酶是复制所需的三种组成型病毒酶之一,是化学疗法干预AIDS的合理靶标,最近在临床环境中也得到了证实。我们在这里报告的N-苄基5,6-二羟基嘧啶-4-羧酰胺的设计和合成作为一类药物,对HIV整合酶催化的链转移过程具有有效的抑制作用。在当前的研究中,对这些分子进行了结构修饰,以检查其对HIV整合酶抑制效能的影响。该系列中最有趣的化合物之一是2- [1-(二甲基氨基)-1-甲基乙基] -N-(4-氟苄基)-5,6-二羟基嘧啶-4-羧酰胺38,CIC95为78 nM。在血清蛋白存在下进行基于细胞的测定。